Rebecca Yue Liang

Title: Rebecca Yue Liang: Innovator in Insulin Receptor Modulators

Introduction

Rebecca Yue Liang is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of biochemistry, particularly in the development of stabilized polypeptide insulin receptor modulators. Her innovative work aims to improve treatments for diabetic conditions and their complications.

Latest Patents

Rebecca Yue Liang holds a patent for "Stabilized polypeptide insulin receptor modulators." This patent describes stabilized α-CT polypeptides that include an alpha-helical segment. The polypeptides are designed to bind to the insulin receptor and incorporate at least one staple or stitch, which consists of cross-linked amino acids. The patent also covers insulin analogs that include these stapled or stitched α-CT polypeptides, along with pharmaceutical compositions and methods of use for treating diabetes.

Career Highlights

Rebecca is affiliated with Harvard College, where she conducts her research and development work. Her innovative approach to insulin receptor modulators has positioned her as a key figure in the field of diabetes treatment. With her expertise, she continues to contribute to advancements in medical science.

Collaborations

Rebecca has collaborated with notable colleagues, including Gregory Lawrence Verdine and Gerard Hilinski. These partnerships have further enhanced her research and development efforts in the field of biochemistry.

Conclusion

Rebecca Yue Liang is a trailblazer in the development of insulin receptor modulators, with her patent reflecting her commitment to improving diabetes treatment. Her work at Harvard College and collaborations with esteemed colleagues underscore her significant impact in the field.